135 related articles for article (PubMed ID: 12731575)
1. Alloantibodies that react with subsets of human T cells.
van Leeuwen A
Tissue Antigens; 1979 Nov; 14(5):437-43. PubMed ID: 12731575
[TBL] [Abstract][Full Text] [Related]
2. Characterization of T lymphocyte and monocyte populations in HLA B8/DRw3 normal individuals and in patients with dermatitis herpetiformis.
Hall RP; Leiserson WM; Chused TM; Lawley TJ
J Invest Dermatol; 1984 Mar; 82(3):231-4. PubMed ID: 6230405
[TBL] [Abstract][Full Text] [Related]
3. Primary biliary cirrhosis associated with HLA-DRw3.
Ercilla G; Parés A; Arriaga F; Bruguera M; Castillo R; Rodés J; Vives J
Tissue Antigens; 1979 Nov; 14(5):449-52. PubMed ID: 12731577
[TBL] [Abstract][Full Text] [Related]
4. Alloantibodies to PHA-activated lymphocytes detect human Qa-like antigens.
Gazit E; Gothelf Y; Gil R; Orgad S; Pitman TB; Watson AL; Yang SY; Yunis EJ
J Immunol; 1984 Jan; 132(1):165-9. PubMed ID: 6606664
[TBL] [Abstract][Full Text] [Related]
5. [T-helper (CD4+) cytopenia and HLA-A1, -B8, -C27, -DR3].
Kuntz BM; Sobieraj B; Brüster HT
Beitr Infusionsther Transfusionsmed; 1994; 32():310-3. PubMed ID: 9480115
[TBL] [Abstract][Full Text] [Related]
6. A1, Cw7, B8, DR3 HLA antigen combination associated with rapid decline of T-helper lymphocytes in HIV-1 infection. A report from the Multicenter AIDS Cohort Study.
Kaslow RA; Duquesnoy R; VanRaden M; Kingsley L; Marrari M; Friedman H; Su S; Saah AJ; Detels R; Phair J
Lancet; 1990 Apr; 335(8695):927-30. PubMed ID: 1970024
[TBL] [Abstract][Full Text] [Related]
7. [Detection of isoimmune antibodies against a population of human B-lymphocytes].
Zotikov EA; Tananov AT; Udovichenko AI; Katandzhan NM
Biull Eksp Biol Med; 1978 Sep; 86(9):324-6. PubMed ID: 308820
[TBL] [Abstract][Full Text] [Related]
8. Immunogenicity of serum HLA antigens in allogeneic combinations.
Pellegrino MA; Indiveri F; Fagiolo U; Antonello A; Ferrone S
Transplantation; 1982 May; 33(5):530-3. PubMed ID: 6953687
[TBL] [Abstract][Full Text] [Related]
9. Immune abnormalities associated with HLA-B8: lymphocyte subsets and functional correlates.
McCombs CC; Michalski JP; deShazo R; Bozelka B; Lane JT
Clin Immunol Immunopathol; 1986 Apr; 39(1):112-20. PubMed ID: 3485020
[TBL] [Abstract][Full Text] [Related]
10. A rapid solid-phase rosette-inhibition assay for the detection of Fc receptor (FcRII)-blocking alloantibodies [corrected].
Hadley AG; Leader K; Laundy G; Smith A; Klouda P; Bradley BA
Immunol Lett; 1991 Mar; 27(3):215-20. PubMed ID: 2060973
[TBL] [Abstract][Full Text] [Related]
11. Specific "intra-allele" and "intra-broad antigen" human leukocyte antigen alloantibodies in kidney graft transplantation.
Muro M; González-Soriano MJ; Salgado G; López R; Boix F; López M; Campillo JA; Martínez P; Botella C; Gimeno L; Minguela A; Alvarez-López MR; Llorente S
Hum Immunol; 2010 Sep; 71(9):857-60. PubMed ID: 20510320
[TBL] [Abstract][Full Text] [Related]
12. Soluble interleukin-2 receptor secretion defect in vitro in HLA-B8, DR3 positive subjects.
Modica MA; di Lorenzo G; Galluzzo A; Giordano C; Portelli MR; Candore G; Caruso C
Autoimmunity; 1990; 7(2-3):87-96. PubMed ID: 2104185
[TBL] [Abstract][Full Text] [Related]
13. Impaired lymphocyte responsiveness to phytohaemagglutinin associated with the possession of HLA-B8/DR3.
Amer A; Singh G; Darke C; Dolby AE
Tissue Antigens; 1986 Oct; 28(4):193-8. PubMed ID: 3492778
[TBL] [Abstract][Full Text] [Related]
14. Recognition of nonclassical HLA class I antigens by gamma delta T cells during pregnancy.
Barakonyi A; Kovacs KT; Miko E; Szereday L; Varga P; Szekeres-Bartho J
J Immunol; 2002 Mar; 168(6):2683-8. PubMed ID: 11884433
[TBL] [Abstract][Full Text] [Related]
15. Identification of HLA-linked antigens by pregnancy-associated non-cytotoxic alloantisera.
MacLeod AM; Mather AJ; Mason RJ; Stewart KN; Power DA; Innes A; Catto GR
Int Arch Allergy Appl Immunol; 1986; 81(1):51-7. PubMed ID: 3488967
[TBL] [Abstract][Full Text] [Related]
16. Failure to find interference between anti-HLA antibodies and chlorpromazine.
Alexander RC; Coggiano MA; Wyatt RJ
Biol Psychiatry; 1990 Mar; 27(6):642-8. PubMed ID: 2322624
[TBL] [Abstract][Full Text] [Related]
17. Defective expression of CD95 (FAS/APO-1) molecule suggests apoptosis impairment of T and B cells in HLA-B8, DR3-positive individuals.
Stassi G; Todaro M; De Maria R; Candore G; Cigna D; Caruso C; Galluzzo A; Giordano C
Hum Immunol; 1997 Jun; 55(1):39-45. PubMed ID: 9328788
[TBL] [Abstract][Full Text] [Related]
18. Frequency of alloantibodies reacting with PHA-activated T lymphocytes, unexplainable by known HLA activities.
Kim SJ; Christiansen FT; Gosar I; Silver DM; Pollack MS; Dupont B
Hum Immunol; 1980 Dec; 1(4):347-55. PubMed ID: 6973560
[TBL] [Abstract][Full Text] [Related]
19. [C4d]FlowPRA screening--a specific assay for selective detection of complement-activating anti-HLA alloantibodies.
Wahrmann M; Exner M; Haidbauer B; Schillinger M; Regele H; Körmöczi G; Böhmig GA
Hum Immunol; 2005 May; 66(5):526-34. PubMed ID: 15935890
[TBL] [Abstract][Full Text] [Related]
20. Human TCR-gamma/delta alloreactive response to HLA-DR molecules. Comparison with response of TCR-alpha/beta.
Flament C; Benmerah A; Bonneville M; Triebel F; Mami-Chouaib F
J Immunol; 1994 Oct; 153(7):2890-904. PubMed ID: 8089476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
